EXISTING drugs already dished out on the NHS could slash dementia risk, a new study has revealed. While new drugs are ...
The first patients have been recruited to an “incredibly exciting” study seeking a blood test to revolutionise dementia ...
In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...
One London clinic has become the first in Europe to offer the drug privately for an 'eye-watering' annual sum, after the NHS ...
These treatments are also only approved for people with early-stage Alzheimer’s or mild cognitive impairment. Strange said that of the three patients he recently referred to a specialist for the new ...
A nationwide clinical trial aiming to revolutionise how dementia is diagnosed is now underway. Research teams will assess how ...
Despite decades of research and billions of dollars in investment, only a few drugs have been approved for dementia and most ...
Researchers from the universities of Cambridge and Exeter identified several medications - already licensed and in use - with ...
Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...
Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...
Common anti-inflammatory drugs such as ibuprofen may cut dementia risk, a major medicines study suggests. Researchers ...
Patients across the UK will take part in the study where their blood will be tested for a series of proteins - called ...